Molecular to Clinical Perspectives in Arrhythmogenic Cardiomyopathy: Current Understanding and Future Therapeutic Directions
The FASEB Journal · 30.11.2026 · 40 (22)
DOI: 10.1096/fj.202604154r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 13.11.2026. Verfasst von Vipin Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, China. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Arrhythmias, Cardiac. Die Arbeit nennt 269 Literaturangaben. Gefördert von: National Natural Science Foundation, Jilin Provincial Foundation.
Abstract (Originalsprache)
Arrhythmogenic cardiomyopathy (ACM), a genetic heart muscle disease that affects primarily the right ventricle, can lead to sudden cardiac death. Although ACM was initially classified as a dysplasia due to a congenital abnormality in the growth of the right ventricle, it was later demonstrated to be caused by a genetic defect in the cardiac desmosomes. Mutations in genes that encode components of the desmosomes, that is, the adhesive junctions that connect cardiomyocytes, are the most common cause of ACMs. However, the specific molecular mechanisms that lead to myocardial destruction, remodeling, and arrhythmogenic predisposition are unclear. Recent advances in the understanding of the pathogenic mechanisms of ACM have focused on mechanisms including cardiomyocyte loss, fibrosis, and adipogenesis, which occur through different signaling pathways such as Wnt signaling, PPARγ signaling, and the Hippo‐Yes‐associated protein pathway. Inflammation also plays a role in the development of ACM. Regarding the diagnosis of ACM, the International Task Force Criteria distinguish between minor and major ACM criteria, with an emphasis on family history, conduction defects, morphological and microstructural changes, repolarization defects, and arrhythmias. In the management and prevention of sudden cardiac death and ventricular tachyarrhythmias, epicardial and endocardial ablation with electromagnetic mapping and the use of an implantable cardiac defibrillator have emerged as useful approaches. We provide an overview of the genetics, histological features, molecular mechanisms, clinical presentation, diagnosis, biomarkers and treatment advances of ACM, including gene therapy, small‐molecule and drug‐based therapies, implantable cardioverter defibrillators, radiofrequency ablation, lifestyle interventions, heart transplantation and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, China.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Nursing, The Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.
- Department of Cardiovascular Disease, The First Hospital of Jilin University, Changchun, China.
- Department of Cardiology and Hypertension, The Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.
- Department of Community Health and Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Xian Wu Cheng
Förderung
- National Natural Science Foundation
- Jilin Provincial Foundation
Zitieren
APA
Kumar, V., Narisawa, M., Meng, K., Shu, S., Liu, M., & Cheng, X. W. (2026). Molecular to Clinical Perspectives in Arrhythmogenic Cardiomyopathy: Current Understanding and Future Therapeutic Directions. The FASEB Journal, 40(22). https://doi.org/10.1096/fj.202604154r
Vancouver
Kumar V, Narisawa M, Meng K, Shu S, Liu M, Cheng XW. Molecular to Clinical Perspectives in Arrhythmogenic Cardiomyopathy: Current Understanding and Future Therapeutic Directions. The FASEB Journal. 2026;40(22). doi:10.1096/fj.202604154r
BibTeX
@article{Kumar2026,
author = {Kumar, Vipin and Narisawa, Megumi and Meng, Kai and Shu, Shangzhi and Liu, Meilan and Cheng, Xian Wu},
title = {Molecular to Clinical Perspectives in Arrhythmogenic Cardiomyopathy: Current Understanding and Future Therapeutic Directions},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {22},
doi = {10.1096/fj.202604154r}
}
EUVIMED